Biofrontera Inc. (BFRI) Earnings Call Transcripts

16 earnings calls from November 2022 to June 11, 2026

NasdaqCM US Health Care Pharmaceuticals

Biofrontera Inc.'s Latest Earnings Call - June 11, 2026

Biofrontera Inc. held its Annual Meeting of Stockholders on June 11, 2026, where key proposals were approved, including the election of directors and an amendment to the company's incentive plan. However, the transcript lacks specific financial results such as revenue and earnings for the quarter or fiscal year, leaving investors without critical performance metrics or guidance updates. The absence of financial data may lead to uncertainty regarding the company's current standing and future outlook.

Reported metrics

MetricValueContext
Revenue
Earnings
Director Votes 11,630,133 (positive) out of 16,750,083 eligible votes, approximately 69.4% participation
Incentive Plan Shares 8,750,000 (positive) increased from 3,750,000 shares

What analysts pressed on

Analysts expressed concerns regarding the lack of disclosed financial performance metrics during the meeting. The absence of revenue and earnings data raises questions about the company's current financial health and future growth prospects.

Main topics on the call

Read the full Biofrontera Inc. transcript (June 11, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Biofrontera Inc.

Biofrontera Inc. (BFRI) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning November 14, 2022 to June 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 16 Biofrontera Inc. earnings call transcripts on record, spanning November 14, 2022 to June 11, 2026. Based on this history, Biofrontera Inc. reports quarterly. The most recent call on file is dated June 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
BFRI
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
16
First call
November 14, 2022
Most recent
June 11, 2026
Reporting cadence
quarterly
Quarter Date
Shareholder/Analyst Calls Jun 11, 2026 Read transcript
Q1 FY2026 May 14, 2026 Read transcript
Q4 FY2025 Mar 19, 2026 Read transcript
Q3 FY2025 Nov 13, 2025 Read transcript
Q2 FY2025 Aug 14, 2025 Read transcript
Q1 FY2025 May 16, 2025 Read transcript
Q4 FY2024 Mar 21, 2025 Read transcript
Earnings Calls Nov 14, 2024 Read transcript
Q2 FY2024 Aug 15, 2024 Read transcript
Q1 FY2024 May 16, 2024 Read transcript
Q4 FY2023 Mar 18, 2024 Read transcript
Q3 FY2023 Nov 10, 2023 Read transcript
Q2 FY2023 Aug 11, 2023 Read transcript
Q1 FY2023 May 12, 2023 Read transcript
Q4 FY2022 Mar 8, 2023 Read transcript
Earnings Calls Nov 14, 2022 Read transcript